T1	chemical 0 14	Growth hormone
T4	disease_or_phenotypic_feature 110 121	Skin cancer
T5	disease_or_phenotypic_feature 123 143	rheumatoid arthritis
T7	chemical 183 193	Fluoxetine
T8	disease_or_phenotypic_feature 211 217	autism
T16	disease_or_phenotypic_feature 462 468	cancer
T19	disease_or_phenotypic_feature 583 586	AMD
T20	disease_or_phenotypic_feature 591 599	cataract
T22	chemical 641 652	amphetamine
T23	chemical 661 669	dopamine
T24	disease_or_phenotypic_feature 681 688	obesity
T26	chemical 710 717	digoxin
T27	disease_or_phenotypic_feature 748 761	heart failure
T32	disease_or_phenotypic_feature 886 907	peripheral neuropathy
T33	disease_or_phenotypic_feature 980 993	breast cancer
T34	chemical 1040 1049	estradiol
T38	disease_or_phenotypic_feature 1231 1245	POEMS syndrome
T39	disease_or_phenotypic_feature 1247 1271	congestive heart failure
T40	chemical 1276 1287	thalidomide
T43	disease_or_phenotypic_feature 1358 1369	hypokalemia
T52	chemical 1679 1691	Nitric oxide
T54	disease_or_phenotypic_feature 1713 1719	cancer
T55	chemical 1729 1737	Propofol
T56	chemical 1756 1766	anesthetic
T57	disease_or_phenotypic_feature 1833 1839	injury
T59	chemical 1853 1862	vitamin E
T60	chemical 1884 1900	ferrous chloride
T61	disease_or_phenotypic_feature 1901 1909	seizures
T62	chemical 1922 1928	oxygen
T63	disease_or_phenotypic_feature 1929 1937	seizures
T64	disease_or_phenotypic_feature 1961 1969	seizures
T65	chemical 2016 2023	antigen
T66	disease_or_phenotypic_feature 2036 2042	cancer
T67	chemical 2043 2050	antigen
T68	chemical 2060 2063	His
T69	disease_or_phenotypic_feature 2064 2072	seizures
T70	chemical 2104 2118	anticonvulsant
T71	disease_or_phenotypic_feature 2145 2162	cerebellar ataxia
T72	disease_or_phenotypic_feature 2281 2287	ptosis
T73	disease_or_phenotypic_feature 2330 2337	obesity
T74	chemical 2355 2369	growth hormone
T3	disease_or_phenotypic_feature 79 108	sporadic optic pathway tumors
R2	causes_or_contributes_to Arg1:T1 Arg2:T3	
T75	corrected_chemical 149 181	tumor necrosis factor inhibitors
T9	chemical 391 428	Nipple fluid carcinoembryonic antigen
T10	chemical 433 458	prostate-specific antigen
T11	corrected_chemical 690 704	ACE inhibitors
R13	treats Arg1:T11 Arg2:T27	
R14	treats Arg1:T26 Arg2:T27	
T15	missed_chemical 1008 1022	growth factors
R15	causes_or_contributes_to Arg1:T15 Arg2:T33	
R16	causes_or_contributes_to Arg1:T34 Arg2:T33	
R17	treats Arg1:T52 Arg2:T54	
T28	corrected_disease_or_phenotypic_feature 1825 1839	hypoxia injury
T31	chemical 1583 1593	anesthesia
T35	disease_or_phenotypic_feature 1598 1606	cataract
T29	chemical 1371 1380	Pazopanib
T36	disease_or_phenotypic_feature 1507 1525	pale laser lesions
R21	treats Arg1:T59 Arg2:T63	
T45	corrected_chemical 1998 2023	prostate-specific antigen
T46	corrected_chemical 2043 2059	antigen (CA)15.3
T47	corrected_chemical 2104 2124	anticonvulsant drugs
T48	missed_disease_or_phenotypic_feature 2130 2140	somnolence
T80	chemical 763 772	Vitamin D
R25	treats Arg1:T59 Arg2:T64	
T13	missed_chemical 1942 1952	penicillin
R26	causes_or_contributes_to Arg1:T13 Arg2:T64	
T82	disease_or_phenotypic_feature 102 108;39 74	tumors neurofibromatosis type 1-associated
R1	causes_or_contributes_to Arg1:T1 Arg2:T82	
T6	chemical 601 609	Dopamine
R5	causes_or_contributes_to Arg1:T29 Arg2:T36	
T12	disease_or_phenotypic_feature 1415 1428	retinal wound
T17	disease_or_phenotypic_feature 1804 1821	cerebral ischemia
R8	treats Arg1:T55 Arg2:T17	
R9	treats Arg1:T55 Arg2:T28	
R10	treats Arg1:T47 Arg2:T69	
T30	chemical 2204 2228	low dose anticonvulsants
R11	causes_or_contributes_to Arg1:T30 Arg2:T48	
R12	causes_or_contributes_to Arg1:T30 Arg2:T71	
T2	missed_disease_or_phenotypic_feature 1223 1229	tumors
T25	missed_chemical 1200 1207	hormone
R3	causes_or_contributes_to Arg1:T25 Arg2:T2	
T37	missed_chemical 1182 1190	estrogen
R4	causes_or_contributes_to Arg1:T37 Arg2:T2	
R6	causes_or_contributes_to Arg1:T62 Arg2:T63	
R7	causes_or_contributes_to Arg1:T60 Arg2:T61	
R18	treats Arg1:T59 Arg2:T61	
